SI0726766T1 - Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound - Google Patents
Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compoundInfo
- Publication number
- SI0726766T1 SI0726766T1 SI9530603T SI9530603T SI0726766T1 SI 0726766 T1 SI0726766 T1 SI 0726766T1 SI 9530603 T SI9530603 T SI 9530603T SI 9530603 T SI9530603 T SI 9530603T SI 0726766 T1 SI0726766 T1 SI 0726766T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pharmaceutical composition
- pct
- ace inhibitor
- composition containing
- novel pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 239000005541 ACE inhibitor Substances 0.000 title abstract 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 title abstract 2
- HDACQVRGBOVJII-JBDAPHQKSA-N ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 title abstract 2
- 229960003401 ramipril Drugs 0.000 title abstract 2
- -1 dihydropyridine compound Chemical class 0.000 title 1
- PVHUJELLJLJGLN-INIZCTEOSA-N (S)-nitrendipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC([N+]([O-])=O)=C1 PVHUJELLJLJGLN-INIZCTEOSA-N 0.000 abstract 1
- RZTAMFZIAATZDJ-HNNXBMFYSA-N 5-o-ethyl 3-o-methyl (4s)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC(Cl)=C1Cl RZTAMFZIAATZDJ-HNNXBMFYSA-N 0.000 abstract 1
- 229940127291 Calcium channel antagonist Drugs 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 239000000480 calcium channel blocker Substances 0.000 abstract 1
- 125000004925 dihydropyridyl group Chemical class N1(CC=CC=C1)* 0.000 abstract 1
- 229960003580 felodipine Drugs 0.000 abstract 1
- GKQPCPXONLDCMU-CCEZHUSRSA-N lacidipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C GKQPCPXONLDCMU-CCEZHUSRSA-N 0.000 abstract 1
- 229960004340 lacidipine Drugs 0.000 abstract 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 abstract 1
- 229960001597 nifedipine Drugs 0.000 abstract 1
- 229960005425 nitrendipine Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9402924A SE9402924D0 (sv) | 1994-09-02 | 1994-09-02 | Novel pharmaceutical composition |
| SE9402925A SE9402925D0 (sv) | 1994-09-02 | 1994-09-02 | Novel oral pharmaceutical composition |
| PCT/SE1995/000972 WO1996007400A1 (en) | 1994-09-02 | 1995-08-30 | Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI0726766T1 true SI0726766T1 (en) | 2002-10-31 |
Family
ID=26662130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9530603T SI0726766T1 (en) | 1994-09-02 | 1995-08-30 | Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6086919A (cs) |
| EP (1) | EP0726766B1 (cs) |
| JP (1) | JP3776931B2 (cs) |
| KR (1) | KR100438133B1 (cs) |
| CN (1) | CN1134665A (cs) |
| AT (1) | ATE217187T1 (cs) |
| AU (1) | AU695865B2 (cs) |
| CA (1) | CA2174338C (cs) |
| CZ (1) | CZ292224B6 (cs) |
| DE (2) | DE69526640T2 (cs) |
| DK (1) | DK0726766T3 (cs) |
| EE (1) | EE03550B1 (cs) |
| EG (1) | EG24435A (cs) |
| ES (1) | ES2091173T3 (cs) |
| FI (1) | FI117616B (cs) |
| GR (1) | GR960300055T1 (cs) |
| HU (1) | HU226894B1 (cs) |
| IL (1) | IL115059A (cs) |
| IS (1) | IS1781B (cs) |
| MX (1) | MX9601586A (cs) |
| MY (1) | MY119489A (cs) |
| NO (1) | NO308694B1 (cs) |
| NZ (2) | NZ292298A (cs) |
| PL (1) | PL186745B1 (cs) |
| PT (1) | PT726766E (cs) |
| RU (1) | RU2184563C2 (cs) |
| SA (1) | SA95160287B1 (cs) |
| SI (1) | SI0726766T1 (cs) |
| SK (1) | SK283633B6 (cs) |
| TR (1) | TR199501077A2 (cs) |
| TW (1) | TW483763B (cs) |
| WO (1) | WO1996007400A1 (cs) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19715594A1 (de) | 1997-04-15 | 1998-10-22 | Bayer Ag | Analgetika-Kombination |
| AU1042199A (en) * | 1998-11-06 | 2000-05-29 | Boehringer Ingelheim International Gmbh | Antihypertensive medicaments containing lacidipine and telmisartan |
| PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
| CA2382549C (en) | 1999-08-30 | 2005-03-15 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| KR100356374B1 (ko) * | 2000-09-14 | 2002-10-19 | 사회복지법인삼성생명공익재단(삼성서울병원) | 안지오텐신 전환효소 억제제의 부작용으로 발생하는마른기침을 저해하기 위한 철분을 포함하는 기침 저해조성물 |
| CA2357982A1 (en) * | 2001-09-28 | 2003-03-28 | Bernard Charles Sherman | Solid compositions comprising ramipril |
| AU2003201071A1 (en) * | 2002-01-15 | 2003-07-30 | Ranbaxy Laboratories Limited | Stable pharmaceutical compositions comprising ace inhibitor(s) |
| USD481456S1 (en) | 2002-01-30 | 2003-10-28 | Smithkline Beecham P.L.C. | Capsule |
| US6844361B2 (en) * | 2002-02-04 | 2005-01-18 | Aventis Pharma Deutschland Gmbh | Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor |
| US20030175342A1 (en) * | 2002-03-14 | 2003-09-18 | Karl Kolter | Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate |
| US20030211149A1 (en) * | 2002-05-07 | 2003-11-13 | Sherman Bernard Charles | Extended release tablets comprising felodipine |
| US6663892B1 (en) | 2002-08-19 | 2003-12-16 | L. Perrigo Company | Multiple portion tablet |
| US20040147566A1 (en) * | 2002-10-16 | 2004-07-29 | Amedeo Leonardi | Lisinopril/lercanidipine combination therapy |
| US20050101640A1 (en) * | 2002-10-16 | 2005-05-12 | Recordati Ireland Limited | Lisinopril/lercanidipine combination therapy |
| WO2004052362A1 (en) * | 2002-12-10 | 2004-06-24 | Novartis Ag | Combination of an dpp-iv inhibitor and a ppar-alpha compound |
| GB0301471D0 (en) * | 2003-01-22 | 2003-02-19 | Biochemie Gmbh | Organic compounds |
| PT1635792E (pt) * | 2003-06-26 | 2009-05-15 | Teva Pharma | Composições farmacêuticas estáveis de derivados do ácido 2-aza-biciclo[3.3.0]octano-3-carboxílico |
| JP2007517766A (ja) * | 2003-09-24 | 2007-07-05 | コンビナトアールエックス インコーポレーティッド | 薬物の組み合わせを投与するための治療法 |
| DE102004008804A1 (de) * | 2004-02-20 | 2005-09-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Mehrschichttablette |
| GB2411355B (en) | 2004-02-27 | 2006-02-22 | Niche Generics Ltd | Pharmaceutical composition |
| TW200534879A (en) * | 2004-03-25 | 2005-11-01 | Bristol Myers Squibb Co | Coated tablet formulation and method |
| US7829720B2 (en) * | 2004-05-04 | 2010-11-09 | Bristol-Myers Squibb Company | Process for preparing atazanavir bisulfate and novel forms |
| US20050256314A1 (en) * | 2004-05-04 | 2005-11-17 | Soojin Kim | Process employing controlled crystallization in forming crystals of a pharmaceutical |
| US20050288343A1 (en) * | 2004-05-19 | 2005-12-29 | Andrew Rusowicz | Process of preparing substituted carbamates and intermediates thereof |
| US7838031B2 (en) | 2004-05-21 | 2010-11-23 | Lawrence Solomon | Method of administering a partial dose using a segmented pharmaceutical tablet |
| WO2005112897A2 (en) * | 2004-05-21 | 2005-12-01 | Accu-Break Technologies, Inc. | Immediate release pharmaceutical tablets with height greater than width |
| US7713547B2 (en) | 2004-05-21 | 2010-05-11 | Accu-Break Pharmaceuticals, Inc. | Method of administering a partial dose of a segmented pharmaceutical tablet |
| US7318935B2 (en) * | 2004-05-21 | 2008-01-15 | Accu-Break Technologies, Inc. | Pharmaceutical tablets with active and inactive segments |
| US7780985B2 (en) * | 2005-07-12 | 2010-08-24 | Accu-Break Technologies, Inc. | Tablets having a printed separation mark to guide breaking |
| US7622137B2 (en) * | 2004-05-21 | 2009-11-24 | Accu-Break Technologies, Inc. | Dosage forms contained within a capsule or sachet |
| US7329418B2 (en) * | 2004-05-21 | 2008-02-12 | Accu Break Technologies, Inc. | Pharmaceutical tablets having height greater than width |
| TWI354569B (en) * | 2004-05-28 | 2011-12-21 | Bristol Myers Squibb Co | Coated tablet formulation and method |
| KR100593795B1 (ko) | 2004-10-12 | 2006-06-30 | 대원제약주식회사 | 안정성이 개선된 라미프릴을 포함하는 경구투여용 제제 |
| RU2007120817A (ru) * | 2004-11-05 | 2008-12-10 | Кинг Фармасьютикалз Рисерч Энд Дивелопмент | Стабилизированные покрытие по отдельности частицы рамиприла, композиции и способы |
| KR100714616B1 (ko) * | 2005-06-23 | 2007-05-07 | 삼성전기주식회사 | 지수 함수 발생기 및 이를 이용한 가변 이득 증폭기 |
| WO2007016256A2 (en) * | 2005-07-28 | 2007-02-08 | Reliant Pharmaceuticals, Inc. | Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof |
| WO2007056442A1 (en) * | 2005-11-07 | 2007-05-18 | King Pharmaceuticals Research & Development, Inc. | Compositions of stabilized ramipril in combination with another active agent |
| JP5259413B2 (ja) * | 2005-11-18 | 2013-08-07 | エーシーシーユー−ブレイク テクノロジーズ，インク． | セグメント化した薬の剤形 |
| US20070237815A1 (en) * | 2006-04-06 | 2007-10-11 | Lawrence Solomon | Dosage forms and methods comprising amlodipine and chlorthalidone |
| RU2008145115A (ru) * | 2006-04-19 | 2010-05-27 | Тева Фармасьютикл Индастриес Лтд. (Il) | Стабильные фармацевтические композиции производственных соединений 2-аза-бицикло[3.3.0]-октан-3-карбоновой кислоты |
| EP2068840A2 (en) * | 2006-07-21 | 2009-06-17 | LAB International SRL | Hydrophobic abuse deterrent delivery system |
| WO2008021875A2 (en) * | 2006-08-08 | 2008-02-21 | Accu-Break Technologies, Inc. | Pharmaceutical tablets containing a plurality of active segments |
| CA2671092A1 (en) * | 2006-11-30 | 2008-06-05 | Accu-Break Technologies, Inc. | Divisible osmotic dosage forms and methods of use |
| GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
| GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
| GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
| CN101778625A (zh) * | 2007-06-22 | 2010-07-14 | 百时美施贵宝公司 | 含有阿扎那韦的压片组合物 |
| EP2170292B1 (en) * | 2007-06-22 | 2014-01-08 | Bristol-Myers Squibb Holdings Ireland | Tableted compositions containing atazanavir |
| ES2360336T3 (es) * | 2007-06-22 | 2011-06-03 | Bristol-Myers Squibb Company | Composiciones en comprimidos que contienen atazanavir. |
| KR20100033377A (ko) * | 2007-06-22 | 2010-03-29 | 브리스톨-마이어스 스큅 컴퍼니 | 아타자나비르를 함유하는 정제 조성물 |
| WO2009092819A1 (en) * | 2008-01-25 | 2009-07-30 | Duo-Ge | Combination of oral medicaments bonded by a wrapping |
| CN102164581A (zh) | 2008-07-28 | 2011-08-24 | 武田药品工业株式会社 | 药物组合物 |
| DE102008059206A1 (de) * | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum |
| SI23149A (sl) | 2009-09-21 | 2011-03-31 | Silverstone Pharma | Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni |
| CN101843892B (zh) * | 2010-05-18 | 2013-03-06 | 广州白云山制药股份有限公司广州白云山制药总厂 | 包括依那普利速释部分和非洛地平缓释部分的药物组合物制剂 |
| KR20170026635A (ko) * | 2014-07-17 | 2017-03-08 | 제롬 쉔타그 | 장기 재생을 위한 내인성 회장 브레이크 호르몬 경로의 활성화 및 관련 조성물, 치료 방법, 진단법, 및 조절 시스템 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
| DE2117571C3 (de) * | 1971-04-10 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
| SE429652B (sv) * | 1978-06-30 | 1983-09-19 | Haessle Ab | 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester |
| DE3413710A1 (de) * | 1984-04-12 | 1985-10-24 | Hoechst Ag, 6230 Frankfurt | Verfahren zur behandlung der herzinsuffizienz |
| NZ212895A (en) * | 1984-08-22 | 1988-07-28 | Glaxo Spa | 1,4-dihydropyridine derivatives and pharmaceutical compositions |
| DE3437917A1 (de) * | 1984-10-17 | 1986-04-17 | Bayer Ag, 5090 Leverkusen | Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln |
| DE3633496A1 (de) * | 1986-10-02 | 1988-04-14 | Hoechst Ag | Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln |
| DE3704661A1 (de) * | 1987-02-14 | 1988-08-25 | Hoechst Ag | Annelierte azepinon- und azocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung |
| US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
| CA1323833C (en) * | 1987-04-28 | 1993-11-02 | Yatindra M. Joshi | Pharmaceutical compositions in the form of beadlets and method |
| DE3739690A1 (de) * | 1987-11-24 | 1989-06-08 | Hoechst Ag | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen |
| TW197945B (cs) * | 1990-11-27 | 1993-01-11 | Hoechst Ag | |
| DE4109134A1 (de) * | 1991-03-20 | 1992-09-24 | Knoll Ag | Erzeugnisse, enthaltend verapamil und trandolapril |
| CA2070085A1 (en) * | 1991-05-31 | 1992-12-01 | Gerald P. Polli | Ace inhibitor and calcium channel blocker for use in treating hypertension |
| US5160744A (en) * | 1991-06-27 | 1992-11-03 | Alza Corporation | Verapmil therapy |
| US5178867A (en) * | 1991-08-19 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug in short-time period |
| PT804229E (pt) * | 1995-03-16 | 2003-06-30 | Pfizer | Utilizacao de amlodipina de um dos seus sais ou defelodipina em combinacao com um inibidor da en zima de conversao da angiotensina (ace) para no fabrico de um medicamento destinado ao tratamento da insuficiencia cardiaca congestiva nao isquemica |
-
1995
- 1995-08-21 TW TW084108719A patent/TW483763B/zh not_active IP Right Cessation
- 1995-08-24 IL IL11505995A patent/IL115059A/xx not_active IP Right Cessation
- 1995-08-24 MY MYPI95002506A patent/MY119489A/en unknown
- 1995-08-29 TR TR95/01077A patent/TR199501077A2/xx unknown
- 1995-08-30 PT PT95930771T patent/PT726766E/pt unknown
- 1995-08-30 DE DE69526640T patent/DE69526640T2/de not_active Expired - Lifetime
- 1995-08-30 AU AU34029/95A patent/AU695865B2/en not_active Expired
- 1995-08-30 PL PL95314084A patent/PL186745B1/pl unknown
- 1995-08-30 EE EE9600072A patent/EE03550B1/xx unknown
- 1995-08-30 NZ NZ292298A patent/NZ292298A/en not_active IP Right Cessation
- 1995-08-30 CN CN95190823A patent/CN1134665A/zh active Pending
- 1995-08-30 SK SK558-96A patent/SK283633B6/sk not_active IP Right Cessation
- 1995-08-30 EP EP95930771A patent/EP0726766B1/en not_active Expired - Lifetime
- 1995-08-30 SI SI9530603T patent/SI0726766T1/xx unknown
- 1995-08-30 ES ES95930771T patent/ES2091173T3/es not_active Expired - Lifetime
- 1995-08-30 KR KR1019960702254A patent/KR100438133B1/ko not_active Expired - Lifetime
- 1995-08-30 WO PCT/SE1995/000972 patent/WO1996007400A1/en not_active Ceased
- 1995-08-30 RU RU96112139/14A patent/RU2184563C2/ru active
- 1995-08-30 DE DE0726766T patent/DE726766T1/de active Pending
- 1995-08-30 HU HU9601146A patent/HU226894B1/hu unknown
- 1995-08-30 AT AT95930771T patent/ATE217187T1/de active
- 1995-08-30 CA CA002174338A patent/CA2174338C/en not_active Expired - Lifetime
- 1995-08-30 US US08/522,267 patent/US6086919A/en not_active Expired - Lifetime
- 1995-08-30 CZ CZ19961173A patent/CZ292224B6/cs not_active IP Right Cessation
- 1995-08-30 DK DK95930771T patent/DK0726766T3/da active
- 1995-08-30 JP JP50941696A patent/JP3776931B2/ja not_active Expired - Lifetime
- 1995-08-31 EG EG73295A patent/EG24435A/xx active
- 1995-10-03 SA SA95160287A patent/SA95160287B1/ar unknown
-
1996
- 1996-04-18 IS IS4337A patent/IS1781B/is unknown
- 1996-04-29 NO NO961726A patent/NO308694B1/no not_active IP Right Cessation
- 1996-04-29 MX MX9601586A patent/MX9601586A/es unknown
- 1996-05-02 FI FI961863A patent/FI117616B/fi not_active IP Right Cessation
- 1996-10-31 GR GR960300055T patent/GR960300055T1/el unknown
-
1998
- 1998-01-08 NZ NZ329556A patent/NZ329556A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR960300055T1 (en) | Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound | |
| DE60018100D1 (en) | Polymorphe form von atorvastatin-calcium | |
| FI960102A0 (fi) | Uusi farmaseuttinen seos | |
| HU9603042D0 (en) | Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration | |
| IL128059A (en) | Pharmaceutical compositions for treatment and prevention of arteriosclerosis containing insulin resistance improving agents, angiotensin ii receptor antagonists and angiotensin converting enzyme inhibitors | |
| HU0104085D0 (en) | Method for the treatment of pulmonary hypertension | |
| FI972434A0 (fi) | Lamotrigiiniä sisältävä farmaseuttinen koostumus | |
| NZ320355A (en) | Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6- tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis | |
| MY100256A (en) | Antihypertensive combination product. | |
| GR3030022T3 (en) | Use of a combination of an ACE-inhibitor with a calcium antagonist in the treatment of proteinuria. | |
| NZ268110A (en) | Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage | |
| MX9710002A (es) | Nuevo uso medico. |